Generex Biotechnology Corporation Revenue and Competitors

Miramar, FL USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Generex Biotechnology Corporation's estimated annual revenue is currently $2.6M per year.(i)
  • Generex Biotechnology Corporation's estimated revenue per employee is $155,000

Employee Data

  • Generex Biotechnology Corporation has 17 Employees.(i)
  • Generex Biotechnology Corporation grew their employee count by -6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.6M8840%N/AN/A
#2
$1.4M929%N/AN/A
#3
$3.6M23-12%N/AN/A
#4
$4.5M2912%N/AN/A
#5
$2.5M16N/AN/AN/A
#6
$0.9M6200%N/AN/A
#7
$1.4M9-18%N/AN/A
#8
$3.7M24-11%N/AN/A
#9
$2.5M16-11%N/AN/A
#10
$0.9M620%N/AN/A
Add Company

Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital. Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products. Our newly formed, wholly-owned subsidiary, NuGenerex Distribution Solutions (NDS), integrates our MSO network with a pharmacy network, clinical diagnostic lab, durable medical equipment company (DME-IQ) and dedicated call center.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$2.6M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Generex Biotechnology Corporation News

2022-04-19 - Diabetes Therapeutics Market Trending Technologies, SWOT ...

Astellas Pharma Inc. Biocon Limited Diasome Pharmaceuticals, Inc. Generex Biotechnology Corp. MannKind Corporation Pfizer Inc. Table of Content:.

2022-04-13 - Global Peptide Cancer Vaccine Market Research Report 2022: Industry Analysis, Trends, Market Size, and Forecasts, 2019-2027 - ResearchAndMarkets.com

The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest ... Generex Biotechnology Corporation.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M17-37%N/A
#2
$1.7M19-39%N/A
#3
$2M2082%N/A
#4
$7.5M20-20%N/A
#5
$2.1M2111%N/A